CompoAtlas

MIGRAINE SUPPORT AND HEADACHE PREVENTION AID

Natural health product licensed in Canada

Other names
MIGRAGUARD MIGRAINE PREVENTION AID, MIGRAINE & HEADACHE AID, MIGRAINE GUARD EXTRA, MIGRAINE GUARD EXTRA HEADACHE AID, MIGRAINE GUARD EXTRA HEADACHE PREVENTION AID, MIGRAINE GUARD HEADACHE AID, MIGRAINE SHIELD HEADACHE PREVENTION AID
Licence holder
HERBACURE NATURAL INC.
NPN or DIN-HM
80105537
Status
Active licence
Licence date
21 October 2020
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Riboflavine

Source : Riboflavine

50 mg100,000 µg
Magnésium

Source : Oxyde de magnésium

125 mg250,000 µg
Tanacetum parthenium

Potency : 0.5 % Parthenolide

100 mgNot calculated
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : Agrobacterium rhizogenes - Whole

100 mgNot calculated
Scutellaria lateriflora

Source : Scutellaria lateriflora - Sommité (herbe)

Extract : Matériel brut sec

Extraction ratio : 2.5:1

Dry plant equivalent : 125 mg

50 mgNot calculated
1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine

Source : Piperine

2.5 mgNot calculated
1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine

Source : Piper nigrum - fruit

2.5 mgNot calculated

Non-medicinal ingredients

Acide stéarique, Hypromellose, Stéarate de magnésium, Cellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to prevent magnesium deficiency. Provides/Source of/An electrolyte (for the maintenance of good health). Feverfew is used in Herbal Medicine to help prevent migraine headaches. Feverfew is used in Herbal Medicine to help reduce the severity and/or frequency of migraine headaches and associated symptoms such as nausea and vomiting, when taken as a prophylactic. Coenzyme Q10 helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic/preventative. Skullcap is traditionally used in Herbal Medicine to help relieve restlessness and/or nervousness (calmative).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80105537

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Tanacetum parthenium
    Read the warning, when it applies and the studies cited

    FEVERFEW - TANACETUM PARTHENIUM

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Biggs et al. 1982).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing 250 mg or less of dried herb top and/or leaf, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are breastfeeding (Boon 2000).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 250 mg or less of dried herb top and/or leaf, per day.

    Do not use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 250 mg of dried herb top and/or leaf, per day.

    Do not use if you are pregnant or breastfeeding (EMA 2020).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2020; Paulsen et al. 2001; Hausen 1996).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product you may experience sore mouth, mouth ulcers and/or gastrointestinal discomfort/disturbances (EMA 2020; Gardner and McGuffin 2013; Murphy et al. 1988; Johnson et al. 1985).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Scutellaria lateriflora
    Read the warning, when it applies and the studies cited

    SKULLCAP - SCUTELLARIA LATERIFLORA

    Route of administration: Oral

    Cautions and warnings

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Bradley 2006; Tilgner 1999; Williamson et al. 1988; Ellingwood 1983; Felter and Lloyd 1983).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Barnes et al. 2007; Boon and Smith 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line